Victoria Haynes - Koninklijke DSM Insider

Koninklijke DSM N V -- USA Stock  

USD 24.94  0.000001  0.00%

Member of the Supervisory Board

Dr. Victoria Haynes has served as Independent Member of the Supervisory Board of Royal DSM NV since May 11, 2012. The last position she held was President and CEO of the Research Triangle Institute International. Currently she serves as Member of the Board of Directors of PPG, Nucor and, as of 2013, Axiall. She is Member of the Company Audit Committee.
Age: 69  Executive Since 2012  Ph.D    
31 45 578 2864

Victoria Haynes Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.87 % which means that it generated profit of $3.87 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 26.89 % meaning that it generated $26.89 on every $100 dollars invested by stockholders.
The company has accumulated 3.26 B in total debt with debt to equity ratio (D/E) of 37.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Koninklijke DSM N V has Current Ratio of 2.39 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 1 records


Chris SuhMicrosoft Corporation

Entity Summary

Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands. Koninklijke DSM is traded on OTC Market in USA.Koninklijke DSM N V (RDSMY) is traded on OTC Market in USA. It is located in Het Overloon 1 and employs 21,054 people.

Did you try this?

Run Equity Analysis Now

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Hide  View All  NextLaunch Equity Analysis

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Koninklijke DSM N V to your portfolio

Top Management

Koninklijke DSM N Leadership Team
Robert Routs, Chairman, Ph.D
Eileen Kennedy, Executive
Ewald Kist, Chairman
Frits Paasschen, Executive
John Ramsay, Executive
Stefan Doboczky, Executive, MBA
Stephan Tanda, Executive
Geraldine Matchett, CFO
Dimitri Vreeze, Executive
Dave Huizing, President
Pauline Mohr, Executive
Victoria Haynes, Executive, Ph.D
Pradeep Pant, Executive
Feike Sijbesma, Chairman
Pierre Hochuli, Executive
Tom Swaan, Executive

Stock Performance

Koninklijke DSM Performance Indicators